Comparison of five staging systems in hepatocellular carcinoma treated with sorafenib: A single-center experience

To the best of our knowledge, none of the prognostic staging systems for hepatocellular carcinoma (HCC) patients who underwent sorafenib therapy is universally adopted or preferred. In the present study, we aimed to compare prognostic ability among five prognostic systems, including the Japan Integr...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Mol Clin Oncol
Glavni autori: ENDO, MASATSUGU, NISHIKAWA, HIROKI, KITA, RYUICHI, KIMURA, TORU, OHARA, YOSHIAKI, SAKAMOTO, AZUSA, SAITO, SUMIO, NISHIJIMA, NORIHIRO, NASU, AKIHIRO, KOMEKADO, HIDEYUKI, OSAKI, YUKIO
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2016
Teme:
Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4812352/
https://ncbi.nlm.nih.gov/pubmed/27073653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2016.755
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items